TELA Bio (NASDAQ:TELA) Receives New Coverage from Analysts at Piper Jaffray Companies

Share on StockTwits

Piper Jaffray Companies assumed coverage on shares of TELA Bio (NASDAQ:TELA) in a research note published on Tuesday morning, Benzinga reports. The firm issued an overweight rating and a $17.00 target price on the stock.

TELA opened at $12.96 on Tuesday. TELA Bio has a 12-month low of $10.78 and a 12-month high of $15.05.

In related news, Director Matt Zuga acquired 86,121 shares of TELA Bio stock in a transaction on Friday, November 8th. The stock was purchased at an average cost of $12.09 per share, with a total value of $1,041,202.89. Also, major shareholder Orbimed Advisors Llc acquired 384,615 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was bought at an average price of $12.09 per share, for a total transaction of $4,649,995.35.

About TELA Bio

TELA Bio, Inc, a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. It offers reinforced tissue matrix products for a variety of reconstruction procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery.

Further Reading: What is FinTech?

Receive News & Ratings for TELA Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TELA Bio and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.